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Abstract
Rationale: The evidence base for rehabilitation in pulmonary
hypertension is expanding, but adoption in clinical practice is
limited.
Objectives: The World Health Organization International
Classification for Functioning, Disability and Health identifies three
health domains: Body Functions/Structures, Activity and
Participation in society. To ensure that the wider impact of
rehabilitation in pulmonary hypertension is accurately assessed, it is
important that study endpoints reflect all three domains.
Methods: A systematic review of the literature was conducted to
identify studies of rehabilitation in patients with pulmonary
hypertension from 2006 to 2019.
Results: Searches across five databases yielded 2,564 articles, of
which 34 met eligibility criteria; 50 different outcome measures
(mean = 5, minimum=1, maximum= 9) were identified. When
mapped onto the World Health Organization International
Classification for Functioning, Disability and Health, 48% of
instances of outcome usage were measures of Body Functions/
Structure, 33% were measures of Activity, and 18% were measures
of Participation. Measures of Participation were not included in
seven studies (21%).
Conclusions: Studies of rehabilitation in pulmonary
hypertension have focused primarily on measures of Body
Functions/Structure; the impact in other health domains is not well
characterized. Greater inclusion of outcome measures reflecting
Activity and Participation in society is needed to allow assessment
of the wider impact of rehabilitation in patients with pulmonary
hypertension.
Keywords: pulmonary hypertension; rehabilitation; outcome
measures
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Pulmonary hypertension (PH) is a condition
with many causes that results in breathlessness,
reduced functional ability, and diminished
quality of life. Once viewed as an untreatable
condition, advances in medical and surgical
treatment have resulted in more people living
with the disease and for longer (1).
Although exercise rehabilitation was
first shown to improve exercise capacity and
quality of life in patients with PH in 2006
(2), greater understanding of the benefits of
rehabilitation in patients with PH is still
required (3, 4). Effective rehabilitation
is a complex, multifaceted intervention
with the potential to impact not only the
underlying health condition but also the
daily lives of patients, their independence,
and their community connections (5). It is
important that this wider potential impact is




The World Health Organization
International Classification for Functioning,
Disability and Health (6) (ICF) is a dynamic
multidimensional classification of health and
health-related domains. It is designed to
support clinicians and health policy makers to
examine and understand the health of
individuals and populations, not simply in
terms of diagnoses but also reflecting the
impact of disease on individuals and the lives
that they are able to live. The ICF considers 1)
Body Functions/Structures (i.e., aspects of
physiology and anatomy), 2) Activity
(i.e., actions and tasks undertaken by
individuals), 3) Participation (i.e., involvement
in life situations), and 4) the environmental and
personal factors that affect these experiences.
To understand the impact of
rehabilitation on patients with PH,
outcomes used in studies of rehabilitation
need to capture the influence of those
interventions across all domains of health.
This study uses the World Health
Organization ICF model as a framework to
examine the literature of rehabilitation
interventions in patients with PH.
Methods
This systematic review comprised
comprehensive searching of the literature
and combined tabular and narrative
synthesis (7). It was prospectively registered
on the PROSPERO database
(CRD42019127590).
Research Aim
Characterization and clinical meaning of
outcome measures in studies of
rehabilitation in patients with PH.
Search Strategy
A comprehensive search was conducted of
the following electronic databases:
MEDLINE (EBSCO); CINAHL Complete
(EBSCO); Cochrane Central Register of
Controlled Trials (Wiley); Scopus (Elsevier);
and ASSIA (Proquest). Searches were
conducted in February 2019 and databases
were monitored for updates until September
2019. The strategy included searches for
words and phrases relating to PH and
exercise or rehabilitation. The Boolean
operators AND and OR were used,
alongside phrase, proximity, and truncation
operators. The search syntax was adapted
accordingly for each information source and
controlled vocabulary terms used where
available.
Where indicated, author and citation
searches were undertaken of papers included
in the review. Searches were conducted for
conference proceedings to identify full articles
if they had been published. Search strategies
for each database are detailed in Appendix E1
in the online supplement.
Study Selection
Selection of studies was undertaken by one
author (C.K.) and a sample was checked at
each stage of selection by a second author
(M.N.H.-G.). Disagreement was resolved by
discussion and consensus involving a third
author (K.S.) as necessary.
Articles from all databases were
combined and duplicates removed before
title and abstract were screened; if studies
were considered to be eligible, then the full
text was reviewed. Studies were included if
they met the following criteria: quantitative
studies of any design, which included
primary data; peer reviewed protocols of
planned studies; and originating from any
time period. Studies were excluded if they
were abstract-only papers; single case
studies (case series were included); review
papers (although references were checked
for primary data sources); or non–English
language papers.
Study populations had to include adults
(age> 18 years) with a diagnosis of PH (8).
Studies were excluded if subjects were
animals; patients with exercise-induced PH;
or patients undergoing postoperative
rehabilitation.
Data Extraction
Data were extracted from all articles that
met the inclusion criteria after full-text
review. Data extraction focused on
identifying study design details for each
article including the rehabilitation
interventions, plus detailed examination of
the outcome measures used.
As the purpose of the study was to
evaluate the outcomemeasures used in studies
of rehabilitation, a risk of bias assessment of
the studies was not performed.
Data Synthesis
Data were examined to identify the
characteristics of the studies as well as the
number and type of outcomes used and their
frequency of use.
Outcomes were categorized
according to type, and the number of
times each outcome was used across
studies was collated. A single outcome
capturing several parameters was
counted only once (e.g., cardiopulmonary
exercise testing or echocardiographic
assessment).
To develop a clear understanding of
what is being measured in studies of
rehabilitation in PH, the outcomes used in
the studies identified in this review were
analyzed against the ICF classification, to
identify whether the outcomes were
measures of the ICF domains of Body
Function/Structure, Activity, or
Participation. Details of each outcome were
examined and items were compared with
the ICF Checklist (9) to determine which
domain or subdomain they represented.
Initial classification was performed by C.K.
before being checked and verified by D.G.K.
and K.S. Disagreement was resolved by
discussion and consensus.
Because PH is a hemodynamic state
arising from a number of causes, there is no
single measure of the disease itself; all
clinical or physiological outcome measures
were classified as measures of body function
or structure. Delineation between Activity
and Participation was based on ICF
guidelines (10) adopting distinct
nonoverlapping sets of Activities (domains
1–4: learning and applying knowledge;
general tasks and demands; communication;
and mobility) and Participation (domains
5–9: self-care; domestic life; interpersonal
interactions and relationships; major life
areas; and community, social, and civic life).
Measures of survival and time to clinical
worsening were determined to be measures
of Body Functions/Structures, as were
outcomes related to use of healthcare
resources. Outcomes that encompassed
more than one of the domains (e.g., Activity
and Participation) were counted in both
categories.
The ICF model considers health in the
context of environmental and personal
factors that may be barriers or facilitators to
patients’ performance. Environmental
factors might include access to supportive
equipment or the building or health system
in which the individual lives; personal
factors may include age, sex, education, or
profession. Although these are important
aspects in understanding the health of an
individual, they are not factors that will be
influenced by rehabilitation interventions
and therefore were not included in this
analysis.
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Results
Searches across five databases yielded 2,564
articles after removal of duplicates. These
were screened on title and abstract, leaving
62 articles that underwent full review and 34
articles that were included in the final data
synthesis, as shown in the flow diagram
(Figure 1). Details of the studies included in
this review are in Table 1.
Studies were published between 2006
and 2019, with the majority of publications
(94%) in the last 10 years (Table 2) reflecting
a growing number of randomized controlled
trials over that time period. Studies were
most commonly of patient populations with
pulmonary arterial hypertension (56%) or
with PH of a nonspecified cause (29%).
Rehabilitation interventions varied in
content and length but were most frequently
a form of whole-body exercise training
involving a mix of cardiovascular,
resistance, and respiratory training
alongside education around disease and
symptom management.
Across the 34 studies in the review, there
were 50 distinct outcome measures used
(Table 3). Studies used an average of 5 outcome
measures (minimum=1, maximum=9)
giving a total of 176 instances of outcome
measure usage across the studies. Exercise
testing (n=56), quality of life measures
(n=31), and biomarkers (n=23) were the
most frequently used, with several different
outcomes being used within each category.
Six-minute walk distance (6MWD) was
used in 32 of the 34 studies; in the 2 studies
not using 6MWD, 1 used cardiopulmonary
exercise testing (11) and 1 attainable
treadmill speed (12). Several studies used
more than one exercise test.
There was no quality of life measure
used in nine (26%) studies. Of these, two
studies used symptom-specific patient-
reported outcomes.
When mapped against the ICF
domains of Body Functions/Structures,
Activity, and Participation, the outcomes
were identified as measures of a single
domain (68%), two domains (14%), or all
three domains (14%). It was not possible to
source sufficiently detailed information to
allow classification for two (4%) of the
outcomes (Living with Pulmonary
Hypertension Questionnaire and Nagasaki
University Respiratory ADL questionnaire).
The most common outcomes were
measures of Body Functions/Structures
(n= 36) followed by measures of Activity
(n= 20) and Participation (n= 13). Figure 2
maps study outcomes to the ICF domains.
When weighted according to the frequency
with which the outcomes were used, 48% of
instances of outcome usage were measures
of Body Functions/Structure, 33% were
measures of Activity, and 18% were
measures of Participation. Seven (21%) of
the studies in this review did not include any
measure of Participation in their outcomes;
the remainder (79%) captured measures
across all three domains.
Table 4 shows further details of the
subdomains of Activity and Participation
included in each of the outcomes. Several
outcomes include only one or two of the
nine possible subdomains, including the
most common, 6MWD. Outcomes
encompassing higher numbers of
subdomains are less frequently used—
Nottingham Health Profile (n= 7),
Cambridge Pulmonary Hypertension
Outcome Review questionnaire (n= 7), and
St. George’s Respiratory Questionnaire
(n= 6). The 36-Item Short Form Health
Full-text articles excluded, with
reasons (n = 28)
• Conference abstract (n = 10)
• Full text not English (n = 7)
• No rehab intervention (n = 4)
• Duplicate (n = 1)
• Postop rehab (n = 2)
• Not peer-reviewed (n = 3)
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This review has examined outcome
measures used in studies of rehabilitation in
PH since the first study published in 2006.
The use of outcome measures is
heterogeneous across the studies, using 50
different outcomes across 34 studies, with an
average of 5 outcomes per study. When
mapped onto the World Health
Organization International Classification
for Functioning, Disability and Health (6), it
is clear that outcomes measuring changes in
Body Functions/Structure predominate,
with fewer measures capturing Activity and
even fewer considering changes in
Participation that might arise from the
rehabilitation intervention. Of the studies
included in this review, 21% did not use any
measure of Participation.
The first randomized controlled trial of
a pharmaceutical intervention in PH in 1990
used 6MWD as its primary endpoint, and
subsequent trials of drug therapies have
tended to follow suit (13). Reflective of the
limitations of 6MWD to capture wider
aspects of health, trials of drug therapies in
PH have incorporated patient-reported
outcomes to capture changes in health-
related quality of life, although these have
been found to be less responsive to
therapeutic impact (14). PH lacks strong
surrogate disease endpoints; the use of
invasive measures such as hemodynamics
has decreased over time in pharmaceutical
studies with a shift instead to composite
endpoints reflecting time to clinical
worsening and, more recently, a focus on
time to clinical improvement (14). Studies of
rehabilitation in PH demonstrate a similar
pattern to studies of pharmacological
interventions, with initial studies focusing
on 6MWD and quality-of-life measures also
being captured, although with less
frequency.
It is understandable that early studies of
rehabilitation in PH chose endpoints used in
trials of pharmacological interventions
where there was evidence for a clinically
meaningful difference. The extensive use of
physiological markers in earlier studies may
be justified to establish the safety and
mechanisms of rehabilitation as a relatively
new intervention; however, the potential for
rehabilitation interventions to have wider
consequences must also be considered
and reflected in the outcome measures
used.
Implications
It is essential that research into
rehabilitation interventions in PH
demonstrates its impact on the issues that
are most important to patients, which will
include not only aspects of Body Functions/
Structure but also Activity and
Participation.
PH impacts the physical, practical,
and social aspects of the daily lives
of patients and their carers. Studies
show the impact of the disease on levels
of anxiety and depression as well as
cognitive function. Emotional and
relationship issues are common, with
high levels of depression and anxiety
(15, 16). In living with the disease
on a day-to-day basis, parameters of
survival, biomarkers, exercise capacity,
and hemodynamics can have less relevance
to patients than their concerns about
employment, reliance on others for help,
or loneliness (17). Diminished quality of
life (18) and reducing the burden of living
with PH are priorities for organizations
supporting patients (19).
Table 2. Study characteristics
Studies [n (%)]
2006–2009 (n=2) 2010–2014 (n=16) 2015–2019 (n= 16) Total (n= 34)
Study design
Prospective single cohort 1 (50) 8 (50) 4 (25) 13 (38)
RCT 1 (50) 3 (19) 8 (50) 12 (3)
Protocol 0 (0) 1 (6) 2 (13) 3 (9)
Nonrandomized two-armed 0 (0) 3 (19) 0 (0) 3 (9)
Retrospective 0 (0) 1 (6) 1 (6) 2 (6)
Case series 0 (0) 0 (0) 1 (6) 1 (3)
Patient population
PAH 1 (50) 8 (50) 10 (63) 19 (56)
PH 1 (50) 5 (31) 4 (25) 10 (29)
PAH or CTEPH 0 (0) 1 (6) 2 (13) 3 (9)
CTEPH 0 (0) 2 (13) 0 (0) 2 (6)
Intervention
Whole-body exercise training 2 (100) 14 (88) 10 (63) 26 (76)
Walking program 0 (0) 2 (12.5) 1 (6) 3 (9)
Inspiratory muscle training 0 (0) 0 (0) 2 (13) 2 (6)
Oscillation plate 0 (0) 0 (0) 1 (6) 1 (3)
Yoga 0 (0) 0 (0) 1 (6) 1 (3)
Mindfulness 0 (0) 0 (0) 1 (6) 1 (3)
Intervention period
Up to 1 mo 0 (0) 0 (0) 2 (13) 2 (6)
2–4 mo 2 (100) 15 (94) 13 (81) 30 (89)
5–12 mo 0 1 (6) 1 (6) 2 (6)
Definition of abbreviations: CTEPH=chronic thromboembolic pulmonary hypertension; PAH=pulmonary arterial hypertension; PH=pulmonary




Table 3. Outcome measures
Category Measure Frequency of
Use
Clinical measure (n=128) Exercise test (n=56) 6MWD 32
CPET 19
5STS 1
Incremental treadmill test 1
Single two-leg jump 1
Attainable treadmill speed 1
Chair-raising test 1
Biomarker (n=23) NT-proBNP 10
Pulmonary function tests 6
Muscle biopsy 2




Thigh muscle area 1
Heart rate recovery 1
Oxygen saturation at rest 1
Cardiac function (n=15) Cardiac function including LV and RV
function (via echo)
5
Right ventricular function (via echo) 3
Cardiac function (via MRI) 3
Hemodynamics (via RHC) 2
Cardiac function (via ECG) 1
Pulmonary perfusion (via MRI) 1
Strength (n=11) Respiratory muscle strength 4
Quadriceps strength 3
Grip strength 2
Upper/lower body muscle power 1
Respiratory muscle endurance 1
Long-term outcomes (n=10) Time to clinical worsening 5
Survival 5
Function (n=10) WHO functional class 10
Physical activity (n=3) Step count 2
Physical activity levels (via accelerometer) 1
Patient-reported outcome
measure (n=48)
Quality of life (n=31) SF-36 19
CAMPHOR 5
EQ-5D 2
Health Promoting Lifestyle Profile II 1
Nottingham Health Profile 1
The Lawton instrumental activities of daily
living scale
1
Nagasaki University Respiratory ADL
questionnaire
1
Living with Pulmonary Hypertension
Questionnaire
1
Symptom-specific measures (n=12) St. George’s Respiratory Questionnaire 2
Fatigue Severity Scale 2
Beck Depression index 2
Hospital Anxiety and Depression Scale 1
Beck Anxiety Index 1
Depression and Anxiety Severity Scale
(DASS21)
1
Baseline and transition dyspnea index 1
MRC dyspnea scale 2
Physical activity (n=3) International Physical Activity Questionnaire 2
Human Activity Profile 1
Health resources (n=2) Health and Social Care Resource Usage 2
Definition of abbreviations: 5STS= five times sit-to-stand test; 6MWD=6-minute walk distance; ADL=activities of daily living; CAMPHOR=Cambridge
Pulmonary Hypertension Outcome Review; CPET=cardio-pulmonary exercise testing; DASS21=Depression and Anxiety Severity Scale; ECG=
electrocardiogram; EQ-5D=quality of life score; LV= left ventricular; MRC=Medical Research Council; MRI =magnetic resonance imaging; NT-
proBNP=N-terminal prohormone of brain natriuretic peptide; RHC= right heart catheter; RV= right ventricular; SF-36=36-item quality of life survey;
WHO=World Health Organization.
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Rehabilitation is a broad term that
captures an active and enabling approach to
optimizing function for individuals.
Rehabilitation in other respiratory diseases
has been shown not only to deliver on
increased physical functioning, as
demonstrated by changes in exercise
capacity, but also to impact aspects of living
with long-term conditions such as fatigue,
emotional function, and understanding and
mastery of the disease and its management
(20).
By limiting the outcomes used to
measure the impact of rehabilitation in PH,
focusing predominantly on clinical and
physiological outcomes as seen in this
review, researchers, clinicians, and service
providers risk overlooking the wider benefits
that might arise from rehabilitation of
patients in this area. The interventions in
most studies in the review are multifaceted,
including psychological and educational
components, yet this is not effectively
reflected in the outcomes captured.
Rehabilitation it is not yet embedded in
clinical practice in PH, despite a growing
evidence base (21). Healthcare resources are
scarce and the case for development of new
services must be compelling. The cost of
caring for people with respiratory disease is
Disease
Pulmonary Hypertension
Outcomes marked with * appear in more than one domain
The number next to each outcome denotes the number of studies in which it is used
Abbreviations:
CAMPHOR: Cambridge Pulmonary Hypertension Outcome Review; CPET: cardio-pulmonary exercise testing;
EQ-5D: quality of life score; NT-proBNP: N-terminal prohormone of brain natriuretic peptide; SF-36: 36 item quality of life
survey; WHO: World Health Organization; 5STS: five times sit-to-stand test: 6MWD: 6 minute walk distance;
Beck Anxiety Index (1)
Beck Depression index (2)
CAMPHOR* (5)
Cardiac Function (via ECG) (1)
Cardiac Function (via echo) (5)
Cardiac Function (via MRI) (3)
CPET (19)
Depression and Anxiety Severity Scale (DASS21) (1)
EQ-5D* (2)
Fatigue Severity Scale* (2)
Grip strength (2)
Haemodynamics (via RHC) (2)
Health and Social Care Resource Usage (2)
Health Promoting Lifestyle Profile II (HPLPII)* (1)
Heart rate recovery (1)
Hospital Anxiety and Depression Scale* (1)
Muscle biopsy (2)
Muscle mass (1)
Nottingham Health Profile (1)
NT-proBNP (10)
Oxygen Saturation at rest (1)
Peripheral muscleforce (quads and handgrip) (1)
Pulmonary function tests (6)
Pulmonary Perfusion (via MRI) (1)
Quadriceps strength (3)
Respiratory Muscle Endurance (1)
Respiratory Muscle Strength (4)
RV function (via echo) (3)
SF-36* (19)
Single two leg jump (1)
St. George’s Respiratory Questionnaire* (2)
Survival (5)
Thigh muscle area (1)
Time to clinical worsening (5)
Upper/lower body muscle power (1)
WHO Functional Class* (10)
Body Functions/Structures
Increased Pulmonary Arterial Pressure




Attainable treadmill speed (1)
Baseline and transition dyspnea index* (1)
CAMPHOR* (5)
Chair raising test (1)
EQ-5D* (2)
Fatigue Severity Scale* (2)
Hospital Anxiety and Depression Scale* (1)
Human Activity Profile* (1)
Incremental Treadmill test (1)
International Physical Activity Questionnaire* (2)
MRC dyspnea scale* (2)
Nottingham Health Profile* (1)
Physical activity levels (via accelerometer) (1)
SF-36* (19)
St. George’s Respiratory Questionnaire* (2)
Step count (2)
The Lawton instrumental activities of daily living scale* (1)
WHO Functional Class* (10)
Activity
Difficulty walking upstairs
Gets tired talking too much
Can’t carry heavy items
Baseline and transition dyspnea index* (1)
CAMPHOR* (5)
EQ-5D* (2)
Fatigue Severity Scale* (2)
Health Promoting Lifestyle Profile II (HPLPII)* (1)
Human Activity Profile* (1)
International Physical Activity Questionnaire* (2)
MRC dyspnea scale* (2)
Nottingham Health Profile* (1)
The Lawton instrumental activities of daily living scale* (1)
SF-36* (19)
St. George’s Respiratory Questionnaire* (2)
WHO Functional Class* (10)
Participation
Reduced working hours
Sees friends less often
Less able to help elderly parents
Figure 2. International Classification for Functioning, Disability and Health classification. 5STS= five times sit-to-stand test: 6MWD=6-minute walk
distance; CAMPHOR=Cambridge Pulmonary Hypertension Outcome Review; CPET=cardiopulmonary exercise testing; ECG=electrocardiogram;
EQ-5D=quality of life score; MRC=Medical Research Council; MRI =magnetic resonance imaging; NT-proBNP=N-terminal prohormone of brain
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significant, arising both frommedical care of
the condition (e.g., drug therapies and
hospital admissions) and from the social
costs of respiratory disease (e.g., inability to
work, requirement for care and support at
home, and dependence on benefits).
Rehabilitation interventions that can be
shown to address these problems, as well as
associated functional limitations on
comorbidities such as mental health and
obesity, are important in making the case for
developing services.
Future Considerations
Measures that capture aspects of Activity
and Participation should be used in studies
of rehabilitation in PH, to assess change
across a broad spectrum of patients’ lives. Of
the outcomes that assess Participation in
this review, SF-36 is the most used, and it is
also widely used in trials of pharmacological
therapies in PH. Although it is a generic
instrument, its measures have been shown
to converge well with other physiological
markers in PH and a minimal clinically
important difference has been estimated
(22). Although several items on the
questionnaire address pain and energy
levels, which fall within the domains of Body
Functions/Structure, it encompasses only




questionnaire is a disease-specific
questionnaire used in five studies in this
review. It addresses issues of breathlessness,
mobility, energy, and the emotional
consequences of living with PH,
encompassing seven of the nine subdomains
in Activity and Participation (Table 4).
Although it may not track other PH clinical
measures over time (14) its validity,
reliability, and minimal clinically important
difference have been established (23).
emPHasis10 (24) is an alternative
PH-specific patient-reported outcome
measure. Initially designed as a tool for use
in clinical practice, it is widely used in this
capacity to monitor disease progression in
patients with PH. Covering five of the nine
domains of Activity and Participation
(Table 4), it is yet to be tested in studies of
rehabilitation.
The use of disease-specific measures may
have less relevance in rehabilitation than in the
assessment of pharmacological therapies or
clinical progress. Many patients with PH will
have significant comorbidities and complex
health problems for which rehabilitation may
also be beneficial. In such situations,
attempting to capture outcomes that reflect
the impact of rehabilitation on a single disease
might overlook the wider benefits to health.
The World Health Organization Disability
Assessment Schedule 2.0 (25) is a self-
administered questionnaire that covers eight
of the nine domains of Activity and
Participation (Table 4). It is not disease
specific; however, its psychometric properties
have been repeatedly validated in diverse
populations, locations, and languages. Its
inclusion of items relating to relationships,
intimacy, dignity, functional activities, and
financial burden, which reflect concerns
frequently raised by people with PH (26),
suggest it may warrant further exploration and
adoption in studies exploring rehabilitation.
Although its use is growing, there is only a
single instance of its use to date in PH, in a
study that uses the measure to characterize
patients with the disease (27). Although used
in only one study of rehabilitation, the
NottinghamHealth Profile covers seven of the
nine domains (Table 4) and thereforemay also
warrant further investigation.
It is likely that the recent global
coronavirus disease (COVID-19) pandemic
will result in an increased number of non–
face-to-face patient assessments taking
place. Outcomes that can be used in this
setting will need to be examined; there may
be an increased use of questionnaires, self-
administered tests, or remote monitoring of
patients.
There are limitations on the ability
of even the most rigorous questionnaires
to fully capture the outcomes of complex
rehabilitation interventions. In-depth
exploration through qualitative research
of patients’ experience of rehabilitation
in PH and the impact on their lives
and the lives of their carers would
also have a valuable role in deepening
our understanding of this important
topic.
Adopting the best measures to capture
the outcomes of rehabilitation will allow
the design, commissioning, and delivery
of services that best meet the needs of
patients.
Conclusions
Studies of rehabilitation in PH have focused
primarily on measures of Body Functions/
Structure; the impact in other domains is
less well characterized. Greater inclusion
of outcome measures reflecting activity
and participation in society is needed to
allow assessment of the wider impact of
rehabilitation in patients with PH. n
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